EDP1503 is a monoclonal strain of Bifidobacterium animalis lactis capable of inducing systemic anti-tumour immunity by activating both innate and adaptive responses characterised by increased cytokine expression including IFN-γ and CXCL10, activation of CD8+ T-cells and a proinflammatory signature within the TME [133]. Here, IFNG is linked to neoplasm.